Boston/ Health & Lifestyle

Teens Chase Height With Black-Market Cancer Drug, Doctors Warn of Lasting Harm

AI Assisted Icon
Published on November 15, 2026
Teens Chase Height With Black-Market Cancer Drug, Doctors Warn of Lasting HarmSource: Swampyank / Wikimedia Commons

The concern around “heightmaxxing” is not just that teens are seeking extra height: some reportedly are obtaining erdafitinib, a cancer drug, through black-market sellers and taking it for that purpose. The drug was developed to treat tumors in adults, and doctors warn that its effects on adolescents could cause lasting harm.

Dr. Chas Hannum, a general pediatrician at Tufts Medical Center, described heightmaxxing as trying to reach “as tall as you can possibly get,” according to Boston 25 News. Hannum said erdafitinib is used to treat bladder cancer in adults. Its unexpected association with significant growth in some patients treated for other medical issues appears to have drawn interest from people seeking height gains.

What Evidence Is Driving the Trend?

The reports of unexpected growth have led some people to believe erdafitinib could make them taller, although it has not been approved or tested for that purpose. A 17-year-old TikTok user identified only as Zak told Rolling Stone that he had taken the drug, sold under the brand name Balversa, on and off since he was 15. He initially paid $300 for a month’s supply from overseas vendors, the outlet reported. Balversa was first approved in 2019 to treat certain advanced bladder cancers in adults, not to help teenagers grow taller.

The same Rolling Stone report described teens sharing growth updates and comparing side effects online. Pediatric endocrinologist Adalbert Raimann told the outlet that the long-term effects of altering the growth receptors targeted by erdafitinib are not known, particularly in children whose bodies are still developing.

What Doctors Say About Potential Harm

Hannum warned that erdafitinib’s effects on adolescents could be serious and irreversible, according to Boston 25 News. He said rapid, uncontrolled bone growth can cause significant spinal or bone problems, including scoliosis. Other possible complications include vision problems, liver issues and mouth sores, he said.

Reports of children who received erdafitinib for unrelated conditions offer examples of the growth complications doctors fear. A 2024 case report described a pre-pubescent child who developed rapid skeletal and long-bone overgrowth that resulted in kyphoscoliosis, according to ScienceDirect. A separate 2024 case report described unexpected growth in two children with central nervous system tumors who were receiving the medication, Rolling Stone reported.

A report by FDA researchers identified five children treated with erdafitinib for brain tumors who developed skeletal growth complications, according to Vice. One 15-year-old grew roughly 5.6 inches in nine months but also developed severe spinal curvature; three of the five children eventually needed surgery, Vice reported. The FDA’s prescribing information says the drug’s safety and effectiveness in pediatric patients have not been established.

What the FDA’s Information Does—and Doesn’t—Show

The FDA prescribing information indicates Balversa for adults with locally advanced or metastatic urothelial cancer with susceptible FGFR3 alterations after prior systemic therapy; it says the drug’s safety and effectiveness in children have not been established. The pediatric reports described above document complications in children treated for other conditions, but they do not establish that erdafitinib is safe or effective for height-seeking teenagers. For people considering prescription medicines from online sellers, the FDA’s BeSafeRx campaign offers guidance on buying medicines safely online. That general guidance does not verify the sellers or supply chain described in this case.

How Social Media May Shape Body-Image Concerns

Heightmaxxing also raises questions about social media’s role in how adolescents view their bodies. A systematic review and meta-analysis of 45 studies involving 33,086 adolescents found that greater social-media engagement was significantly associated with more body-image concerns and eating-disorder symptoms, according to findings published in the Journal of Youth and Adolescence. The association was stronger in studies focused specifically on Instagram than in studies examining social media generally.

Dr. Ellen Braaten, a child psychiatrist at Mass General, told Boston 25 News that social-media-driven trends are appearing more often in her practice. She has seen anxiety among children and parents connected to these trends and cautioned that repeated exposure can make risky behavior seem normal. Braaten said social media can leave a 14-year-old feeling damaged and in need of fixing rather than focused on healthy development.

What Parents Can Do

Braaten advised parents to pay attention to what their children see online and to keep conversations open rather than reacting harshly. Her recommendations, according to Boston 25 News, include looking at what children view, asking them directly about their online habits, and keeping phones and screens out of bedrooms at bedtime. She emphasized that communication can help parents spot dangerous trends before they take hold.